|
Free Research Report Download:
The Cancer Market Outlook To 2014
Free Pharmaceutical Market Research Reports
Biotechnology
Corporate & Fiscal
Drug Delivery
Health Products
Hospital Markets
Indication Areas
Medical Devices
Prescription Medicines
R&D
Custom Research
Pharmaceutical Events & Conferences
Contact
Terms & Conditions
Privacy
Business Market Research
Energy Market Research
Financial Market Research
Pharmaceutical Market Research
Telecoms Market Research
|
Home > Market Research > Indication Areas > The Global Market for Pain Management Drugs and Devices
REPORT HIGHLIGHTS
The global pain-management market is worth around $30.9 billion in 2007. It is forecasted to grow at a compound annual growth rate (CAGR) of 5.63% to reach $40.6 billion by the end of the forecast period, 2012.
The pharmaceuticals segment of the pain-management market is valued at $29 billion in 2007. It will be worth $38 billion by 2012 at a CAGR of 5.6%.
In 2007, market revenue from the medical devices segment is around $1.9 billion. This segment is predicted to grow at a CAGR of 6.5% to reach $2.6 billion by the end of 2012.
INTRODUCTION
The goal of BCC Research in conducting this study was to determine the present status of the worldwide pain-management market and also to evaluate its potential over the five-year period from 2007 to 2012. The pain-management market has been analyzed considering two main segments: pharmaceuticals and devices. The pharmaceuticals segment is further subdivided into different types, such as non-opioids, opioids, anticonvulsants, and antidepressants, whereas the medical devices segments is segmented into transcutaneous electrical nerve stimulation (TENS), spinal cord stimulator (SCS) and peripheral nerve stimulator (PNS), and intrathecal pumps.
SCOPE OF STUDY
This report contains:
The major types of pain-management methods, including drugs (non-opioids, opioids, anticonvulsants, and antidepressants) and devices (transcutaneous electrical nerve stimulation (TENS), spinal cord stimulator (SCS), peripheral nerve stimulator (PNS), and intrathecal pumps)
Analysis of each type of pain-relief technique, determining its current market status, its impact on future markets, and growth over the 5-year period 2007 through 2012
Technological issues, including the latest trends, plus other influential factors, such as patents, new products, and other adjuvant techniques of pain management.
METHODOLOGY
BCC Research presents an analysis by each segment of pain relief, depending on its technique, considering the base year 2007. Estimated values are based on what manufacturers have paid in undepreciated dollars. P>INFORMATION SOURCES
The major sources of information for this study have been primary research done by interviewing a majority of the key players in this industry. Secondary research was compiled from Internet company websites, as well as current financial and trade information, and information from government sources.
Top of Page
Table of Contents
INTRODUCTION
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THIS STUDY
CONTRIBUTIONS TO THE STUDY AND FOR WHOM
SCOPE AND FORMAT
METHODOLOGY
INFORMATION SOURCES
ABOUT THE AUTHOR
RELATED BCC REPORTS
BCC RESEARCH ONLINE SERVICES
DISCLAIMER
SUMMARY
Summary Table:
GLOBAL PAIN-MANAGEMENT MARKET, THROUGH 2012 ($ BILLIONS)
Summary Figure:
SHARE OF GLOBAL PAIN-MANAGEMENT MARKET, BY SEGMENT 2007 AND 2012 (%)
OVERVIEW
OVERVIEW
OVERVIEW (CONTINUED)
Figure 1 PAIN-MANAGEMENT TECHNIQUES
PAIN-MANAGEMENT MARKET
WHAT IS PAIN?
THE PERCEPTION OF PAIN
TYPES OF PAIN
ACUTE PAIN
CHRONIC PAIN
TYPES OF PAIN-MANAGEMENT MEDICATIONS
NSAID
Side Effects of NSAIDs
Table 1 COMMONLY USED NSAIDS
OPIOIDS
Table 2 CLASSES AND EXAMPLES OF OPIOIDS, DEPENDING ON ORIGIN
Table 2 (CONTINUED)
Side Effects of Opioids
ANTICONVULSANTS
Table 3 COMMONLY USED ANTICONVULSANTS IN PAIN MANAGEMENT
ANTIDEPRESSANTS
Table 4 COMMONLY USED ANTIDEPRESSANTS IN PAIN MANAGEMENT
WORLD HEALTH ORGANIZATION PAIN LADDER
Figure 2 WHO ANALGESIC LADDER
TYPES OF PAIN BY APPLICATION
BURN PAIN
Challenges Associated with Burn Pain
Burn Pain Management
Figure 3 BURN PAIN-MANAGEMENT APPROACH
CANCER PAIN
Figure 4 CAUSES OF CANCER PAIN
Types of Cancer Pain
Pain Management in Cancer
Table 5 CANCER PAIN MEDICATION
Description of Some of Key Medications for Cancer Pain Control
Morphine
Fentanyl
Hydromorphone
Methadone
Buprenorphine
Oxycodone
Diamorphine
DENTAL PAIN
Treatment for Dental Pain
Acetaminophen
NSAIDs
COX-2 Inhibitors
Opioids
PEDIATRIC PAIN
Pediatric Pain (Continued)
Pediatric Pain Treatment
Table 6 PEDIATRIC PAIN MANAGEMENT
HEADACHE PAIN
Types of Headache
Primary Headache
Tension Headache
Migraine
Figure 5 PHASES IN MIGRAINES
Cluster Headache
Secondary Headache
Pain Management for Headaches
Pain Relief or Analgesics
Preventive Medication
Abortive Medications
Table 7 PAIN MANAGEMENT IN HEADACHES
Table 7 (CONTINUED)
NEUROPATHIC PAIN
Neuropathic Pain (Continued)
Neuropathic Pain (Continued)
Figure 6 MANAGEMENT OF NEUROPATHIC PAIN
OBSTETRICAL PAIN
Obstetric Pain Management
Regional Anesthesia
SURGICAL PAIN
Pain Management in Surgery
Table 8 SURGICAL PAIN MANAGEMENT
Table 8 (CONTINUED)
MUSCULOSKELETAL PAIN
Arthritis
Lower Back Pain
Musculoskeletal Pain Management
Table 9 TREATMENT OPTIONS FOR MUSCULOSKELETAL PAIN
Table 9 (CONTINUED)
PAIN-MANAGEMENT MARKET ANALYSIS
Table 10 HEALTHCARE DEMOGRAPHICS OF OECD COUNTRIES
Table 10 (CONTINUED)
METHODS THAT PROVIDE PAIN RELIEF
Figure 7 PAIN MANAGEMENT METHODS
PAIN-MANAGEMENT MARKET
Table 11 GLOBAL PAIN-MANAGEMENT MARKET, THROUGH 2012 ($ BILLIONS)
Figure 8 GLOBAL PAIN-MANAGEMENT MARKET, 2005-2012
PHARMACEUTICALS PAIN MANAGEMENT
Table 12 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET FORECAST, THROUGH 2012 ($ BILLIONS)
Figure 9 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET FORECAST, 2005-2012 ($ BILLIONS)
MEDICAL DEVICES PAIN MANAGEMENT
Table 13 GLOBAL MEDICAL DEVICES PAIN-MANAGEMENT MARKET FORECAST, THROUGH 2012 ($ MILLIONS)
Figure 10 GLOBAL MEDICAL DEVICES PAIN-MANAGEMENT MARKET FORECAST, 2005-2012 ($ MILLIONS)
PHARMACEUTICALS PAIN-MANAGEMENT MARKET ANALYSIS
GLOBAL PHARMACEUTICAL PAIN-MANAGEMENT MARKET
Table 14 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET FORECAST, THROUGH 2012 ($ BILLIONS)
Figure 11 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET FORECAST, 2005-2012 ($ BILLIONS)
Table 15 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET BY TYPE, 2007 AND 2012 (%)
Figure 12 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET, 2007 (%)
Figure 13 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET, 2012 (%)
MARKET ANALYSIS BY APPLICATION
Table 16 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET FORECAST BY APPLICATION, THROUGH 2012 ($ BILLIONS)
Table 16 (CONTINUED)
Table 17 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET SHARES BY APPLICATION, 2007 AND 2012 (%)
Figure 14 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET SHARES BY APPLICATION, 2007 (%)
Figure 15 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET SHARES BY APPLICATION, 2012 (%)
GEOGRAPHIC MARKET ANALYSIS
Table 18 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET BY REGION, THROUGH 2012 ($ BILLIONS)
Figure 16 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET BY REGION, 2005-2012 ($ BILLIONS)
GEOGRAPHIC DISTRIBUTION
Table 19 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET SHARES, BY REGION (%)
Figure 17 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET SHARES, BY REGION, 2007 (%)
Figure 18 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET SHARES, BY REGION, 2012 (%)
U.S. PHARMACEUTICALS PAIN-MANAGEMENT MARKET
Table 20 U.S. PHARMACEUTICALS PAIN-MANAGEMENT MARKET, THROUGH 2012 ($ BILLIONS)
Figure 19 U.S. PHARMACEUTICALS PAIN-MANAGEMENT MARKET, 2005-2012 ($ BILLIONS)
EUROPEAN PHARMACEUTICALS PAIN-MANAGEMENT MARKET
Table 21 EUROPEAN PHARMACEUTICALS PAIN-MANAGEMENT MARKET, THROUGH 2012 ($ BILLIONS)
Figure 20 EUROPEAN PHARMACEUTICALS PAIN-MANAGEMENT MARKET, 2005-2012 ($ BILLIONS)
REST-OF-WORLD PHARMACEUTICALS PAIN-MANAGEMENT MARKET
Table 22 REST-OF-WORLD PHARMACEUTICALS PAIN-MANAGEMENT MARKET, THROUGH 2012 ($ BILLIONS)
Figure 21 REST-OF-WORLD PHARMACEUTICALS PAIN-MANAGEMENT MARKET, 2005-2012 ($ BILLIONS)
COMPETITIVE STRUCTURE
TYPE OF COMPETITION
TIERS OF COMPETITION
MERGERS AND ACQUISITIONS
Table 23 KEY MERGERS AND ACQUISITIONS
Table 23 (CONTINUED)
Table 23 (CONTINUED)
END-USER GROUPS
DISTRIBUTION STRUCTURE
COMPETITIVE FACTORS
PRODUCT PIPELINE
Table 24 PAIN-MANAGEMENT DRUG PRODUCT PIPELINES
Table 24 (CONTINUED)
Table 24 (CONTINUED)
Table 24 (CONTINUED)
NON-OPIOID ANALGESIC MARKET
THE NSAIDS MARKET
Table 25 TYPES OF NSAIDS USED IN PAIN MANAGEMENT
KEY CHALLENGES
Table 26 KEY CHALLENGES OF NSAID USE
The Fallout Due to the Vioxx and Bextra Recall
Relief Only for Mild to Moderate Pain
Side Effects Such as Gastric Ulcers and Bleeding
COX Inhibitors Will Replace Traditional NSAID Market Shares
PRODUCT ANALYSIS
THE NSAIDS
Table 27 OTC AND PRESCRIPTION NSAIDS
Table 27 (CONTINUED)
Table 28 NSAIDS AND THEIR USES
TRIPTANS
Table 29 KEY TRIPTANS AVAILABLE
ACETAMINOPHEN
THE COX-2 INHIBITORS
Table 30 COX INHIBITORS
CHALLENGES FACED BY THE COX INHIBITOR MARKET
The Vioxx Recal-Still Fresh in Mind
Only One Product Available in the U.S.
Uncertainty and Delay in the Launch of New COXs
High Prices Lead to Reluctance Among Physicians
MARKET ANALYSIS OF COX INHIBITORS
Table 31 SALES OF COX-2 INHIBITORS, 2002-2006 ($ BILLIONS)
MARKET ANALYSIS
Table 32 GLOBAL NON-OPIOID PAIN-MANAGEMENT MARKET, THROUGH 2012 ($ BILLIONS)
Figure 22 GLOBAL NON-OPIOID PAIN-MANAGEMENT MARKET, 2005-2012 ($ BILLIONS)
>NON-OPIOID MARKET BY REGION
Table 33 GLOBAL NON-OPIOIDAL PAIN-MANAGEMENT MARKET BY REGION, 2007 AND 2012 (%)
Figure 23 GLOBAL NON-OPIOIDAL PAIN-MANAGEMENT MARKET BY REGION, 2007 (%)
Figure 24 GLOBAL NON-OPIOIDAL PAIN-MANAGEMENT MARKET BY REGION, 2012 (%)
COMPETITIVE STRUCTURE
MARKET SHARE ANALYSIS
Table 34 GLOBAL NON-OPIOID PAIN-MANAGEMENT MARKET SHARES ANALYSIS, 2006 (%)
Figure 25 GLOBAL NON-OPIOID PAIN-MANAGEMENT MARKET SHARES ANALYSIS, 2006 (%)
THE OPIOIDS MARKET
KEY CHALLENGES
Table 35 KEY CHALLENGES FACED BY THE OPIOIDS MARKET
RISK OF ADDICTION DISCOURAGES PHYSICIANS TO PRESCRIBE OPIOIDS
LEGAL RISKS INVOLVED WITH PRESCRIPTION OF OPIOIDS
RISK OF POTENTIAL PATIENT ABUSE
SIDE EFFECTS CAUSED BY THE USE OF OPIOIDS DISCOURAGE PATIENTS AS WELL AS PHYSICIANS
LACK OF KNOWLEDGE IN USE AND PRESCRIPTION OF OPIOIDS
LOSS OF SOME KEY PATENTS WILL LEAD TO THE ENTRY OF GENERICS
PRODUCT ANALYSIS
Table 36 CLASSES OF OPIOIDS
Table 37 COMMON OPIOIDS AVAILABLE
COMBINATION OPIOIDS
Table 38 COMMON COMBINATION OPIOIDS AVAILABLE
MARKET ANALYSIS
Table 39 GLOBAL OPIOID PAIN-MANAGEMENT MARKET, THROUGH 2012 ($ BILLIONS)
Figure 26 GLOBAL OPIOID PAIN-MANAGEMENT MARKET, 2005-2012 ($ BILLIONS)
OPIOID MARKET BY REGION
Table 40 GLOBAL OPIOID PAIN-MANAGEMENT MARKET, 2007 AND 2012 (%)
Figure 27 GLOBAL OPIOID PAIN-MANAGEMENT MARKET BY REGION, 2007 (%)
Figure 28 GLOBAL OPIOID PAIN-MANAGEMENT MARKET BY REGION, 2012 (%)
COMPETITIVE STRUCTURE
MARKET SHARE ANALYSIS
Table 41 GLOBAL OPIOID PAIN-MANAGEMENT MARKET SHARE ANALYSIS (%)
Figure 29 GLOBAL OPIOID PAIN-MANAGEMENT MARKET SHARES, 2006 (%)
THE ANTIDEPRESSANTS MARKET
CHALLENGES FACED BY THE ANTIDEPRESSANTS MARKET
Table 42 KEY CHALLENGES IN THE ANTIDEPRESSANTS MARKET
SAFETY CONCERNS PLAGUE THE USE OF ANTIDEPRESSANTS
THE INCREASE IN THE JUVENILE SUICIDE RATE HAS CAUSED CONCERNS
THE DELAY BY DRUGS TO SHOW THEIR EFFECTS
UNFAMILIAR TREATMENT GUIDELINES
PRODUCT ANALYSIS
Table 43 ANTIDEPRESSANTS AVAILABLE IN THE U.S.
MARKET ANALYSIS
Table 44 GLOBAL ANTIDEPRESSANTS PAIN-MANAGEMENT MARKET FORECAST, THROUGH 2012 ($ BILLIONS)
Figure 30 GLOBAL ANTIDEPRESSANTS PAIN-MANAGEMENT MARKET FORECAST, 2005-2012 ($ BILLIONS)
MARKET BY REGION
Table 45 GLOBAL ANTIDEPRESSANTS PAIN-MANAGEMENT MARKET SHARES BY REGION, 2007 AND 2012 (%)
Figure 31 GLOBAL ANTIDEPRESSANTS PAIN-MANAGEMENT MARKET SHARES BY REGION, 2007 (%)
Figure 32 GLOBAL ANTIDEPRESSANTS PAIN-MANAGEMENT MARKET SHARES BY REGION, 2012 (%)
COMPETITIVE STRUCTURE
MARKET SHARE ANALYSIS
Table 46 GLOBAL ANTIDEPRESSANTS MARKET SHARE ANALYSIS, 2006 (%)
Figure 33 GLOBAL ANTIDEPRESSANTS MARKET SHARE ANALYSIS, 2006 (%)
ANTICONVULSANTS MARKET
KEY CHALLENGES
VERY FEW APPROVALS
INTRODUCTION OF GENERIC COMPOUNDS
PRODUCT ANALYSIS
Table 47 ANTICONVULSANTS AVAILABLE IN THE U.S.
MARKET ANALYSIS
Table 48 GLOBAL ANTICONVULSANTS PAIN-MANAGEMENT MARKET, THROUGH 2012 ($ BILLIONS)
Figure 34 GLOBAL ANTICONVULSANTS PAIN-MANAGEMENT MARKET, 2005-2012 ($ BILLIONS)
MARKET BY REGION
Table 49 GLOBAL ANTICONVULSANTS PAIN-MANAGEMENT MARKET BY REGION, 2007 AND 2012 (%)
Figure 35 GLOBAL ANTICONVULSANTS PAIN-MANAGEMENT MARKET BY REGION, 2007 (%)
Figure 36 GLOBAL ANTICONVULSANTS PAIN-MANAGEMENT MARKET BY REGION, 2012
COMPETITIVE STRUCTURE
MARKET SHARE ANALYSIS
Table 50 GLOBAL ANTICONVULSANTS PAIN-MANAGEMENT MARKET SHARE ANALYSIS, 2006 (%)
Figure 37 GLOBAL ANTICONVULSANTS PAIN-MANAGEMENT MARKET SHARE ANALYSIS, 2006 (%)
MEDICAL DEVICES FOR PAIN MANAGEMENT
KEY DRIVERS
Table 51 KEY DRIVERS FOR THE PAIN-MANAGEMENT DEVICES MARKET
TYPES OF DEVICES USED IN PAIN MANAGEMENT
Figure 38 MEDICAL DEVICES USED IN PAIN MANAGEMENT
SPINAL CORD STIMULATOR AND PERIPHERAL NERVE STIMULATORS
Spinal Cord Stimulator and ?(Continued)
TRANSCUTANEOUS ELECTRICAL NERVE MUSCLE STIMULATOR
INTRATHECAL PUMPS AND PATIENT CONTROLLED ANALGESIA
Intrathecal Pumps and ?(Continued)
Intrathecal Pumps and ?(Continued)
OTHER DEVICES USED IN PAIN MANAGEMENT
MARKET ANALYSIS
Table 52 MEDICAL DEVICES PAIN-MANAGEMENT MARKET, THROUGH 2012 ($ MILLIONS)
Figure 39 MEDICAL DEVICES PAIN-MANAGEMENT MARKET, 2005-2012 ($ MILLIONS)
MARKET ANALYSIS BY TYPE
Table 53 MEDICAL DEVICES PAIN-MANAGEMENT MARKET BY SEGMENT (%)
Figure 40 MEDICAL DEVICES PAIN-MANAGEMENT MARKET BY SEGMENT, 2007 (%)
Figure 41 MEDICAL DEVICES PAIN-MANAGEMENT MARKET BY SEGMENT, 2012 (%)
MARKET ANALYSIS BY REGION
Table 54 MEDICAL DEVICES PAIN-MANAGEMENT MARKET BY REGION, THROUGH 2012 ($ MILLIONS)
Figure 42 MEDICAL DEVICES PAIN-MANAGEMENT MARKET BY REGION, 2005-2012 ($ MILLIONS)
Table 55 MEDICAL DEVICES PAIN-MANAGEMENT MARKET SHARES BY REGION, 2007 AND 2012 (%)
Figure 43 MEDICAL DEVICES PAIN-MANAGEMENT MARKET SHARES, BY REGION, 2007 (%)
Figure 44 MEDICAL DEVICES PAIN-MANAGEMENT MARKET SHARES BY REGION, 2012 (%)
COMPETITIVE STRUCTURE
Types of Competition
Tiers of Competition
MERGERS AND ACQUISITIONS
Advanced Neuromodulation Systems and St. Jude Medical
Advanced Bionics Corp. and Boston Scientific
Empi, Inc. and Encore Medical Corp.
ADJUVANT TREATMENT METHODS FOR PAIN MANAGEMENT
ACUPUNCTURE
ACUPUNCTURE (CONTINUED)
ACUPRESSURE
BIOFEEDBACK
HEADACHE
Migraine
Other Headaches
GENERAL PAIN
HYPNOSIS
APPLICATION OF HYPNOSIS
MUSIC THERAPY
LASER THERAPY
MASSAGE THERAPY
REGULATIONS AND KEY ISSUES IN PAIN MANAGEMENT
ROLE OF REGULATIONS IN PAIN MANAGEMENT
DEA SCHEDULE OF CONTROLLED SUBSTANCES
Table 56 DEA SCHEDULE OF CONTROLLED SUBSTANCES
Table 56 (CONTINUED)
THE NATIONAL PAIN CARE POLICY ACT (H.R. 1020)
THE NATIONAL PAIN CARE POLICY ACT (CONTINUED)
IMPACT OF THE NATIONAL PAIN POLICY OF 2005
BARRIERS TO CANCER PAIN
FEAR OF ADDICTION
FEAR OF SIDE EFFECTS
INADEQUATE PAIN ASSESSMENT
INADEQUATE KNOWLEDGE/TRAINING
LEGAL HASSLES
PROBLEMS RELATED TO THE HEALTHCARE SYSTEM
THE PAIN CONSORTIUM
VIOXX RECALL
Table 57 IMPACTS OF THE VIOXX RECALL
THE OXYCONTIN ISSUE
The OxyContin Issue (Continued)
Table 58 IMPACT OF OXYCONTIN ABUSE
COMPANY PROFILES
ABBOTT LABORATORIES
ASTRAZENECA
BAYER HEALTHCARE
BIOVAIL CORP.
ELI LILLY AND CO.
ENCORE MEDICAL
ENDO PHARMACEUTICALS
GLAXOSMITHKLINE, PLC
JAVELIN PHARMACEUTICALS
JOHNSON & JOHNSON
MEDTRONICS, INC.
MERCK & CO., INC
NOVARTIS
PURDUE PHARMACEUTICALS
ROCHE
SANOFI-AVENTIS
ST. JUDE MEDICAL
PATENT ANALYSIS
GENERAL TRENDS
Table 59 NUMBER OF U.S. PATENTS FILED FOR THE FOUR MAJOR SEGMENTS, 1997-2006
Figure 45 NUMBER OF U.S. PATENTS FILED FOR THE FOUR MAJOR SEGMENTS, 1997-2006
PATENT ANALYSES
NSAIDS
Table 60 NSAID PATENT DISTRIBUTION, BY YEAR, 1997-2006 (NUMBER OF PATENTS)
Figure 46 NSAID PATENT DISTRIBUTION BY YEAR, 1997-2006 (NUMBER OF PATENTS)
OPIOIDS
Table 61 OPIOID PATENT DISTRIBUTION BY YEAR, 1997-2006 (NUMBER OF PATENTS)
Figure 47 OPIOID PATENT DISTRIBUTION BY YEAR, 1997-2006 (NUMBER OF PATENTS)
PAIN-MANAGEMENT MEDICAL DEVICES
Table 62 PAIN-MANAGEMENT MEDICAL DEVICE PATENTS BY ASSIGNEE COUNTRY
Figure 48 PAIN-MANAGEMENT MEDICAL DEVICE PATENTS BY ASSIGNEE COUNTRY (NUMBER OF PATENTS)
TRENDS BY COMPANY
Table 63 U.S. PATENTS FILED BY ASSIGNEE COMPANY, 1997-2006
Figure 49 U.S. PATENTS FILED BY ASSIGNEE COMPANY, 1997-2006 (%)
CONCLUSIONS
CONCLUSIONS (CONTINUED)
APPENDIX A: KEY INDUSTRY WEBSITES
KEY REGULATORY AND INFORMATION WEBSITES
KEY MANUFACTURER WEBSITES
APPENDIX B: REVENUES OF KEY PHARMACEUTICAL COMPANIES
Table 64 REVENUES OF SOME KEY PHARMACEUTICAL COMPANIES, 2005 AND 2006 ($ BILLIONS)
CURRENCY CONVERSIONS
LIST OF TABLES
Summary Table:
GLOBAL PAIN-MANAGEMENT MARKET, THROUGH 2012 ($ BILLIONS)
Table 1 COMMONLY USED NSAIDS
Table 2 CLASSES AND EXAMPLES OF OPIOIDS, DEPENDING ON ORIGIN
Table 3 COMMONLY USED ANTICONVULSANTS IN PAIN MANAGEMENT
Table 4 COMMONLY USED ANTIDEPRESSANTS IN PAIN MANAGEMENT
Table 5 CANCER PAIN MEDICATION
Table 6 PEDIATRIC PAIN MANAGEMENT
Table 7 PAIN MANAGEMENT IN HEADACHES
Table 8 SURGICAL PAIN MANAGEMENT
Table 9 TREATMENT OPTIONS FOR MUSCULOSKELETAL PAIN
Table 10 HEALTHCARE DEMOGRAPHICS OF OECD COUNTRIES
Table 11 GLOBAL PAIN-MANAGEMENT MARKET, THROUGH 2012 ($ BILLIONS)
Table 12 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET FORECAST, THROUGH 2012 ($ BILLIONS)
Table 13 GLOBAL MEDICAL DEVICES PAIN-MANAGEMENT MARKET FORECAST, THROUGH 2012 ($ MILLIONS)
Table 14 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET FORECAST, THROUGH 2012 ($ BILLIONS)
Table 15 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET BY TYPE, 2007 AND 2012 (%)
Table 16 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET FORECAST BY APPLICATION, THROUGH 2012 ($ BILLIONS)
Table 17 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET SHARES BY APPLICATION, 2007 AND 2012 (%)
Table 18 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET BY REGION, THROUGH 2012 ($ BILLIONS)
Table 19 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET SHARES BY REGION (%)
Table 20 U.S. PHARMACEUTICALS PAIN-MANAGEMENT MARKET, THROUGH 2012 ($ BILLIONS)
Table 21 EUROPEAN PHARMACEUTICALS PAIN-MANAGEMENT MARKET, THROUGH 2012 ($ BILLIONS)
Table 22 REST-OF-WORLD PHARMACEUTICALS PAIN-MANAGEMENT MARKET, THROUGH 2012 ($ BILLIONS)
Table 23 KEY MERGERS AND ACQUISITIONS
Table 24 PAIN-MANAGEMENT DRUG PRODUCT PIPELINES
Table 25 TYPES OF NSAIDS USED IN PAIN MANAGEMENT
Table 26 KEY CHALLENGES OF NSAID USE
Table 27 OTC AND PRESCRIPTION NSAIDS
Table 28 NSAIDS AND THEIR USES
Table 29 KEY TRIPTANS AVAILABLE
Table 30 COX INHIBITORS
Table 31 SALES OF COX-2 INHIBITORS, 2002-2006 ($ BILLIONS)
Table 32 GLOBAL NON-OPIOID PAIN-MANAGEMENT MARKET, THROUGH 2012 ($ BILLIONS)
Table 33 GLOBAL NON-OPIOIDAL PAIN-MANAGEMENT MARKET BY REGION, 2007 AND 2012 (%)
Table 34 GLOBAL NON-OPIOID PAIN-MANAGEMENT MARKET SHARES ANALYSIS, 2006 (%)
Table 35 KEY CHALLENGES FACED BY THE OPIOIDS MARKET
Table 36 CLASSES OF OPIOIDS
Table 37 COMMON OPIOIDS AVAILABLE
Table 38 COMMON COMBINATION OPIOIDS AVAILABLE
Table 39 GLOBAL OPIOID PAIN-MANAGEMENT MARKET, THROUGH 2012 ($ BILLIONS)
Table 40 GLOBAL OPIOID PAIN-MANAGEMENT MARKET (%)
Table 41 GLOBAL OPIOID PAIN-MANAGEMENT MARKET SHARE ANALYSIS (%)
Table 42 KEY CHALLENGES IN THE ANTIDEPRESSANTS MARKET
Table 43 ANTIDEPRESSANTS AVAILABLE IN THE U.S.
Table 44 GLOBAL ANTIDEPRESSANTS PAIN-MANAGEMENT MARKET FORECAST, THROUGH 2012 ($ BILLIONS)
Table 45 GLOBAL ANTIDEPRESSANTS PAIN-MANAGEMENT MARKET SHARES BY REGION, 2007 AND 2012 (%)
Table 46 GLOBAL ANTIDEPRESSANTS MARKET SHARE ANALYSIS, 2006 (%)
Table 47 ANTICONVULSANTS AVAILABLE IN THE U.S.
Table 48 GLOBAL ANTICONVULSANTS PAIN-MANAGEMENT MARKET, THROUGH 2012 ($ BILLIONS)
Table 49 GLOBAL ANTICONVULSANTS PAIN-MANAGEMENT MARKET BY REGION, 2007 AND 2012 (%)
Table 50 GLOBAL ANTICONVULSANTS PAIN-MANAGEMENT MARKET SHARE ANALYSIS, 2006 (%)
Table 51 KEY DRIVERS FOR THE PAIN-MANAGEMENT DEVICES MARKET
Table 52 MEDICAL DEVICES PAIN-MANAGEMENT MARKET, THROUGH 2012 ($ MILLIONS)
Table 53 MEDICAL DEVICES PAIN-MANAGEMENT MARKET BY SEGMENT (%)
Table 54 MEDICAL DEVICES PAIN-MANAGEMENT MARKET BY REGION, THROUGH 2012 ($ MILLIONS)
Table 55 MEDICAL DEVICES PAIN-MANAGEMENT MARKET SHARES BY REGION, 2007 AND 2012 (%)
Table 56 DEA SCHEDULE OF CONTROLLED SUBSTANCES
Table 57 IMPACTS OF THE VIOXX RECALL
Table 58 IMPACT OF OXYCONTIN ABUSE
Table 59 NUMBER OF U.S. PATENTS FILED FOR THE FOUR MAJOR SEGMENTS, 1997-2006
Table 60 NSAID PATENT DISTRIBUTION, BY YEAR, 1997-2006 (NUMBER OF PATENTS)
Table 61 OPIOID PATENT DISTRIBUTION BY YEAR, 1997-2006 (NUMBER OF PATENTS)
Table 62 PAIN-MANAGEMENT MEDICAL DEVICE PATENTS BY ASSIGNEE COUNTRY
Table 63 U.S. PATENTS FILED BY ASSIGNEE COMPANY, 1997-2006
Table 64 REVENUES OF SOME KEY PHARMACEUTICAL COMPANIES, 2005 AND 2006 ($ BILLIONS)
LIST OF FIGURES
Summary Figure:
SHARE OF GLOBAL PAIN-MANAGEMENT MARKET, BY SEGMENT 2007 AND 2012 (%)
Figure 1 PAIN-MANAGEMENT TECHNIQUES
Figure 2 WHO ANALGESIC LADDER
Figure 3 BURN PAIN-MANAGEMENT APPROACH
Figure 4 CAUSES OF CANCER PAIN
Figure 5 PHASES IN MIGRAINES
Figure 6 MANAGEMENT OF NEUROPATHIC PAIN
Figure 7 PAIN MANAGEMENT METHODS
Figure 8 GLOBAL PAIN-MANAGEMENT MARKET, 2005-2012
Figure 9 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET FORECAST, 2005-2012 ($ BILLIONS)
Figure 10 GLOBAL MEDICAL DEVICES PAIN-MANAGEMENT MARKET FORECAST, 2005-2012 ($ MILLIONS)
Figure 11 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET FORECAST, 2005-2012 ($ BILLIONS)
Figure 12 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET, 2007 (%)
Figure 13 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET, 2012 (%)
Figure 14 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET SHARES BY APPLICATION, 2007 (%)
Figure 15 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET SHARES BY APPLICATION, 2012 (%)
Figure 16 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET BY REGION, 2005-2012 ($ BILLIONS)
Figure 17 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET SHARES BY REGION, 2007 (%)
Figure 18 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET SHARES BY REGION, 2012 (%)
Figure 19 U.S. PHARMACEUTICALS PAIN-MANAGEMENT MARKET, 2005-2012 ($ BILLIONS)
Figure 20 EUROPEAN PHARMACEUTICALS PAIN-MANAGEMENT MARKET, 2005-2012 ($ BILLIONS)
Figure 21 REST-OF-WORLD PHARMACEUTICALS PAIN-MANAGEMENT MARKET, 2005-2012 ($ BILLIONS)
Figure 22 GLOBAL NON-OPIOID PAIN-MANAGEMENT MARKET, 2005-2012 ($ BILLIONS)
Figure 23 GLOBAL NON-OPIOIDAL PAIN-MANAGEMENT MARKET BY REGION, 2007 (%)
Figure 24 GLOBAL NON-OPIOIDAL PAIN-MANAGEMENT MARKET BY REGION, 2012 (%)
Figure 25 GLOBAL NON-OPIOID PAIN-MANAGEMENT MARKET SHARES ANALYSIS, 2006 (%)
Figure 26 GLOBAL OPIOID PAIN-MANAGEMENT MARKET, 2005-2012 ($ BILLIONS)
Figure 27 GLOBAL OPIOID PAIN-MANAGEMENT MARKET BY REGION, 2007 (%)
Figure 28 GLOBAL OPIOID PAIN-MANAGEMENT MARKET BY REGION, 2012 (%)
Figure 29 GLOBAL OPIOID PAIN-MANAGEMENT MARKET SHARES, 2006 (%)
Figure 30 GLOBAL ANTIDEPRESSANTS PAIN-MANAGEMENT MARKET FORECAST, 2005-2012 ($ BILLIONS)
Figure 31 GLOBAL ANTIDEPRESSANTS PAIN-MANAGEMENT MARKET SHARES BY REGION, 2007 (%)
Figure 32 GLOBAL ANTIDEPRESSANTS PAIN-MANAGEMENT MARKET SHARES BY REGION, 2012 (%)
Figure 33 GLOBAL ANTIDEPRESSANTS MARKET SHARE ANALYSIS, 2006 (%)
Figure 34 GLOBAL ANTICONVULSANTS PAIN-MANAGEMENT MARKET, 2005-2012 (% MILLIONS)
Figure 35 GLOBAL ANTICONVULSANTS PAIN-MANAGEMENT MARKET BY REGION, 2007 (%)
Figure 36 GLOBAL ANTICONVULSANTS PAIN-MANAGEMENT MARKET BY REGION, 2012
Figure 37 GLOBAL ANTICONVULSANTS PAIN-MANAGEMENT MARKET SHARE ANALYSIS, 2006 (%)
Figure 38 MEDICAL DEVICES USED IN PAIN MANAGEMENT
Figure 39 MEDICAL DEVICES PAIN-MANAGEMENT MARKET, 2005-2012 ($ MILLIONS)
Figure 40 MEDICAL DEVICES PAIN-MANAGEMENT MARKET BY SEGMENT, 2007 (%) MEDICAL DEVICES PAIN-MANAGEMENT MARKET BY SEGMENT, 2012 (%)
Figure 42 MEDICAL DEVICES PAIN-MANAGEMENT MARKET BY REGION, 2005-2012 ($ MILLIONS)
Figure 43 MEDICAL DEVICES PAIN-MANAGEMENT MARKET SHARES, BY REGION, 2007 (%)
Figure 44 MEDICAL DEVICES PAIN-MANAGEMENT MARKET SHARES BY REGION, 2012 (%)
Figure 45 NUMBER OF U.S. PATENTS FILED FOR THE FOUR MAJOR SEGMENTS, 1997-2006
Figure 46 NSAID PATENT DISTRIBUTION BY YEAR, 1997-2006 (NUMBER OF PATENTS)
Figure 47 OPIOID PATENT DISTRIBUTION BY YEAR
Figure 48 PAIN-MANAGEMENT MEDICAL DEVICE PATENTS BY ASSIGNEE COUNTRY (NUMBER OF PATENTS)
Figure 49 U.S. PATENTS FILED BY ASSIGNEE COMPANY, 1997-2006 (%)
For full details, please email keithw@cmsinfo.com
Top of Page
Buy now!
Top of Page
|
|
